HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
Previous close
$1.71
Day range
$1.70 - $1.80
Year range
$1.40 - $4.24
Market cap
53.64M USD
Avg Volume
354.12K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.43M | 37.39% |
Net income | -4.52M | 44.01% |
Net profit margin | — | — |
Earnings per share | -0.16 | 65.22% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.86M | 31.33% |
Total assets | 11.86M | 36.12% |
Total liabilities | 6.92M | -52.20% |
Total equity | 4.94M | — |
Shares outstanding | 30.31M | — |
Price to book | 10.06 | — |
Return on assets | -123.19% | — |
Return on capital | -316.27% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -4.52M | 44.01% |
Cash from operations | -4.20M | -17.16% |
Cash from investing | — | — |
Cash from financing | 5.46M | 15.78% |
Net change in cash | 1.26M | 12.60% |
Free cash flow | -2.24M | -3.54% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
